Iconic TherapeuticsCompany Details

Get alertedif Iconic Therapeutics gets funded!
United States
Detailed industries:biotechnology
Company description

conic Therapeutics, Inc., an Atlanta, Georgia based biopharmaceutical company, has an exclusive license on issued Yale University patents for a novel recombinant protein called hI-con1™. hI-con1 binds tissue factor


Funding history

Key people
Kirk DornbushCo-Founder, President and Chief Financial Officer, Director, Executive Officer
Todd FoleyDirector
William GreeneCEO, CEO & Board Member, Director, Executive Officer
Michael I. Sherman, Ph.d.Co-Founder, and Chairman
Johan KordelDirector
Bruce RobertsonDirector
Michael ShermanCo-Founder, and Chairman
Jon Soderstrom, Director
Patrick W. TrownChief Scientist
Please note that all data is automatically extracted and errors can occur.
The WhoGotFunded team has not necessarily reviewed the information in this page and has not determined if it is accurate and complete.
Inaccurate Data? Help us improve WhoGotFunded: post a comment!